|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
Massachusetts Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing MassachusettsLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
LifeMap Sciences, Inc.
| | | Phone: | (617) 497-7774 | Fax: | (617) 812-8488 | Year Established: | 2003 | Main Contact: | David Warshawsky, Ph.D., President & CEO | | Other Contacts: | Ronit Shtrichman, Ph.D., MBA, VP, Biology Yaron Guan-Golan, COO Yaron Mazor, Senior VP, Technology, and GM, Israel Operations Kenneth S. Elsner, Esq., CFO & General Counsel Rafhael Cedeno, CTO Michael D. West, Ph.D., CSO
| | Company Description | LifeMap Sciences’ (formerly XenneX) core technology and business is based on its Integrated Biomedical Knowledgebase and discovery platform for biomedical research, which includes GeneCards®, the leading human gene database; LifeMap Discovery®, the database of embryonic development, stem cell research and regenerative medicine; and MalaCards, the human disease database. LifeMap’s products are used in many institutions including academia, research hospitals, patent offices, and leading biotechnology and pharmaceutical companies. In addition to its currently marketed products, LifeMap is pursuing several new internet and informatics products which leverage its existing products and their large user base.
LifeMap Sciences holds the exclusive worldwide license to market GeneCards®and MalaCards from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science. As one of the leading suppliers of online databases for information on genes, cells, and diseases, LifeMap Sciences intends to continually improve the quality of its products as well as extend its applications to the general public through future consumer product offerings in the field of mobile health by its subsidiary LifeMap Solutions, Inc.
On April 20, 2012, BioTime and its wholly owned subsidiary LifeMap Sciences announced an agreement to acquire XenneX. through a merger of XenneX, into LifeMap Sciences. | |
|
|
|
|
|